Contineum Therapeutics
IPOLife Reconnected.
Public · San Diego, United States · Founded 2020 · $160.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- contineum-tx.com
- Total Funding
- $160.0M
- Last Round
- $100.0M Series BJan 2023
- Rounds
- 2
- Type
- Public
About
Contineum Therapeutics is a clinical-stage biopharmaceutical company developing treatments for autoimmune and neurological diseases.
Summary
Contineum Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $160.0M in total across 2 rounds, most recently a $100.0M Series B round in Jan 2023. Investors include Goldman Sachs, RBC Capital Markets and SVB Leerink.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Apr 2024
Sign up to see all 5 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/contineum-therapeutics"><img src="https://indexed.vc/api/badge/company/contineum-therapeutics" alt="Contineum Therapeutics on Indexed.vc" width="260" height="76" /></a>